Table 4.
Variables | HR (95% CI) | P* |
---|---|---|
NCI criteria for disease risk | ||
Standard-risk disease | 1.0 | — |
High-risk disease | 1.2 (0.5-3.2) | .7 |
6MP dose intensity | ||
Per unit increase in dose intensity | 0.99 (0.97-1.01) | .3 |
Blast chromosomal abnormalities | ||
Normal/ none | 1.0 | — |
Favorable | 0.3 (0.08-1.2) | .1 |
Unfavorable | 2.1 (0.4-10.1) | .4 |
Adherence to oral 6MP | ||
≥90% | 1.0 | — |
<90% | 3.9 (1.3-11.3) | .01 |
Analysis was adjusted for time from initiation of maintenance to study entry, and race.
— indicates not applicable.